Rho(D) Immune Globulin Manufacturing and Supply

The contract pertains to the end-to-end manufacturing, quality control, packaging, and delivery of Rho(D) Immune Globulin under strict adherence to FDA regulations, current Good Manufacturing Practices, and Defense Logistics Agency standards. The work must be performed in compliance with all applicable federal requirements to ensure product safety, efficacy, and consistency, with the final product intended for federal use. The subcontract is issued under the NAICS code 325412 for pharmaceutical preparation manufacturing and is sourced through the Department of Defense’s Medical Supply Chain PHARM FSA, with performance required at the designated FPO address under zip code 96678. Submissions must be received by the deadline of May 6, 2026, and bidders are expected to demonstrate proven capability in large-scale biologics production, rigorous quality assurance protocols, and reliable logistics for government distribution channels.